References
- Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–94.
- Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health [Internet]. 2006;120:8–14. [accessed 2018 Feb 3]. http://www.ncbi.nlm.nih.gov/pubmed/16297415
- Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol. 2010;84:3134–46. doi:https://doi.org/10.1128/JVI.01394-09.
- Leung GM, Hedley AJ, Ho L-M, Chau P, Wong IOL, Thach TQ, Ghani AC, Donnelly CA, Fraser C, Riley S, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med [Internet]. 2004;141:662–73. [accessed 2016 Apr 8]. http://www.ncbi.nlm.nih.gov/pubmed/15520422
- Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, Lam WK, Seto WH, Yam LY, Cheung TM, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977–85. doi:https://doi.org/10.1056/NEJMoa030666.
- Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med [Internet]. 2003;348:1995–2005. [accessed 2017 Jan 18]. http://www.ncbi.nlm.nih.gov/pubmed/12671061
- Centers for Disease Control and Prevention (CDC). Outbreak of severe acute respiratory syndrome–worldwide, 2003. MMWR Morb Mortal Wkly Rep [Internet]. 2003;52:226–28. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/12665115
- Centers for Disease Control and Prevention (CDC). Preliminary clinical description of severe acute respiratory syndrome. MMWR Morb Mortal Wkly Rep [Internet]. 2003;52:255–56. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/12680522
- Centers for Disease Control and Prevention (CDC). Update: severe acute respiratory syndrome–United States, June 4, 2003. MMWR Morb Mortal Wkly Rep [Internet]. 2003;52:525–26. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/12803200
- Centers for Disease Control and Prevention (CDC). Severe acute respiratory syndrome (SARS) and coronavirus testing–United States, 2003. MMWR Morb Mortal Wkly Rep [Internet]. 2003;52:297–302. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/12731699
- Centers for Disease Control and Prevention (CDC). Severe acute respiratory syndrome–Singapore, 2003. MMWR Morb Mortal Wkly Rep [Internet]. 2003;52:405–11. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/12807088
- Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol [Internet]. 2004;33:628–34. [accessed 2019 Oct 12]. http://www.ncbi.nlm.nih.gov/pubmed/15155694
- Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med [Internet]. 2012;367:1814–20. [accessed 2016 Jan 17]. http://www.ncbi.nlm.nih.gov/pubmed/23075143
- Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill [Internet]. 2012;17. [accessed 2019 May 10]. http://www.ncbi.nlm.nih.gov/pubmed/23041020
- de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RAM, Galiano M, Gorbalenya AE, ZA M, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol [Internet]. 2013;87:7790–92. doi:https://doi.org/10.1128/JVI.01244-13.
- Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, Landt O, Assiri A, Eckerle I, Al Shangiti A, et al. An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014. Clin Infect Dis [Internet]. 2015;60:369–77. [accessed 2016 Apr 15]. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4303774&tool=pmcentrez&rendertype=abstract
- Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DAT, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med [Internet]. 2013;369:407–16. [accessed 2016 Feb 24]. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4029105&tool=pmcentrez&rendertype=abstract
- Memish ZA, Al-Tawfiq JA, Alhakeem RF, Assiri A, Alharby KD, Almahallawi MS, Alkhallawi M. Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases. Travel Med Infect Dis [Internet]. 2015;13:311–14. doi:https://doi.org/10.1016/j.tmaid.2015.06.012. .
- El Bushra HE, Abdalla MN, Al Arbash H, Alshayeb Z, Al-Ali S, Latif Z-A-A, Al-Bahkit H, Abdalla O, Mohammed M, Al-Abdely H, et al. An outbreak of Middle East respiratory syndrome (MERS) due to coronavirus in Al-Ahssa Region, Saudi Arabia, 2015. East Mediterr Health J [Internet]. 2016;22:468–75. [accessed 2017 May 6]. http://www.ncbi.nlm.nih.gov/pubmed/27714741
- Balkhy HH, Alenazi TH, Alshamrani MM, Baffoe-Bonnie H, Al-Abdely HM, El-Saed A, Al Arbash HA, Al Mayahi ZK, Assiri AM, Bin Saeed A. Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital–Riyadh, Saudi Arabia, 2015. MMWR Morb Mortal Wkly Rep [Internet]. 2016;65:163–64. [accessed 2016 Dec 31]. http://www.cdc.gov/mmwr/volumes/65/wr/mm6506a5.htm
- Balkhy HH, Alenazi TH, Alshamrani MM, Baffoe-Bonnie H, Arabi Y, Hijazi R, Al-Abdely HM, El-Saed A, Al Johani S, Assiri AM, et al. Description of a hospital outbreak of Middle East respiratory syndrome in a large tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol [Internet]. 2016;37:1147–55. [accessed 2017 May 6]. https://www.cambridge.org/core/product/identifier/S0899823X1600132X/type/journal_article
- Assiri AM, Biggs HM, Abedi GR, Lu X, Bin Saeed A, Abdalla O, Mohammed M, Al-Abdely HM, Algarni HS, Alhakeem RF, et al. Increase in Middle East respiratory syndrome-coronavirus cases in saudi arabia linked to hospital outbreak with continued circulation of recombinant virus, July 1-August 31, 2015. Open Forum Infect Dis [Internet]. 2016;3:ofw165. [accessed 2016 Oct 7]. http://www.ncbi.nlm.nih.gov/pubmed/27704019
- Nazer RI. Outbreak of Middle East respiratory syndrome-coronavirus causes high fatality after cardiac operations. Ann Thorac Surg [Internet]. 2017;104:e127–9. [accessed 2017 Sep 5]. http://www.ncbi.nlm.nih.gov/pubmed/28734432
- Assiri A, Abedi GR, Bin Saeed AA, Abdalla MA, al-Masry M, Choudhry AJ, Lu X, Erdman DD, Tatti K, Binder AM, et al. Multifacility outbreak of middle east respiratory syndrome in Taif, Saudi Arabia. Emerg Infect Dis [Internet]. 2016;22:32–40. [accessed 2017 Jun 26] http://wwwnc.cdc.gov/eid/article/22/1/15-1370_article.htm
- Hunter JC, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K, Khudair A, Al Mulla M, El Saleh F, Imambaccus H, et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis [Internet]. 2016;22:647–56. [accessed 2016 Dec 31]. http://wwwnc.cdc.gov/eid/article/22/4/15-1615_article.htm
- Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, Ferguson NM. Transmission scenarios for middle east respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart. Euros Urveillance. 2013;18:20503.
- Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis [Internet]. 2014;14:50–56. [accessed 2016 Dec 31]. http://linkinghub.elsevier.com/retrieve/pii/S1473309913703049
- Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, et al. Hospital-associated outbreak of middle east respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description. Clin Infect Dis [Internet] 2014;59:1225–33. [accessed 2017 May 13]. http://www.ncbi.nlm.nih.gov/pubmed/24829216
- Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med [Internet] 2015;13:210. [accessed 2016 Dec 31]. http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0450-0.
- Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, Alsheikh S, Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Heal J [Internet] 2013; 19(Suppl 1):S12–8. [accessed 2016 Mar 5] http://www.ncbi.nlm.nih.gov/pubmed/23888790
- Al-Tawfiq JA, Memish ZA. Drivers of MERS-CoV transmission: what do we know? Expert Rev Respir Med [Internet]. 2016;10:331–38. [accessed 2016 Jul 8] http://www.ncbi.nlm.nih.gov/pubmed/26848513
- Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI, et al. 2014 MERS-CoV outbreak in Jeddah–a link to health care facilities. N Engl J Med [Internet]. 2015; 372:846–54. doi:https://doi.org/10.1056/NEJMoa1408636.
- Alraddadi B, Bawareth N, Omar H, Alsalmi H, Alshukairi A, Qushmaq I, Feteih M, Qutob M, Wali G, Khalid I. Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital. Ann Thorac Med [Internet]. 2016 [accessed 2016 Dec 31]; 11:128–31. http://www.thoracicmedicine.org/text.asp?2016/11/2/128/180027
- Fagbo SF, Skakni L, Chu DKW, Garbati MA, Joseph M, Peiris M, Hakawi AM. Molecular epidemiology of hospital outbreak of Middle East respiratory syndrome, Riyadh, Saudi Arabia, 2014. Emerg Infect Dis [Internet]. 2015;21:1981–88. [accessed 2016 Dec 31]. http://wwwnc.cdc.gov/eid/article/21/11/15-0944_article.htm
- Almekhlafi GA, Albarrak MM, Mandourah Y, Hassan S, Alwan A, Abudayah A, Altayyar S, Mustafa M, Aldaghestani T, Alghamedi A, et al. Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients. Crit Care [Internet]. 2016;20:123. [accessed 2016 Dec 31]. http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1303-8
- Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MAA, Mutairi MA, Nakhli DA, Aidaroos AYA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis [Internet]. 2014;29:301–06. [accessed 2019 Feb 25]. http://www.ncbi.nlm.nih.gov/pubmed/25303830
- Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis. 2013;13:752–61. doi:https://doi.org/10.1016/S1473-3099(13)70204-4.
- Nam H-S, Park JW, Ki M, Yeon M-Y, Kim J, Kim SW. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis [Internet]. 2017 [accessed 2017 Mar 21]. http://linkinghub.elsevier.com/retrieve/pii/S1201971217300541
- Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet [Internet] 2020. https://linkinghub.elsevier.com/retrieve/pii/S0140673620301859
- World Health Organization. Situation Report-17 SITUATION IN NUMBERS total and new cases in last 24 hours [Internet]. 2020 [accessed 2020 Feb 7]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200206-sitrep-17-ncov.pdf?sfvrsn=17f0dca_2
- Van Griensven J, Edwards T, De Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016;374:33–42. doi:https://doi.org/10.1056/NEJMoa1511812.
- Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S. The spike protein of SARS-CoV–a target for vaccine and therapeutic development. Nat Rev Microbiol [Internet]. 2009;7:226–36. doi:https://doi.org/10.1038/nrmicro2090.
- Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, et al. Treatment of 5 critically Ill patients with covid-19 with convalescent plasma. JAMA - J Am Med Assoc. 2020;323:1582–89. doi:https://doi.org/10.1001/jama.2020.4783.
- Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, Ling Y, Xun J, Lu L, Jiang S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv [Internet]. 2020 [aaccessed 2020 May 15]. doi: https://doi.org/10.1101/2020.03.30.20047365.
- Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490–96. doi:https://doi.org/10.1073/pnas.2004168117.
- Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, Rojas-Villarraga A, Ramírez-Santana C, Díaz-Coronado JC, Manrique R, et al. Convalescent plasma in Covid-19: possible mechanisms of action. Autoimmun Rev [Internet]. 2020;102554. [accessed 2020 May 15]. https://linkinghub.elsevier.com/retrieve/pii/S1568997220301166
- Hung IF, To KK, Lee C-K, Lee K-L, Chan K, Yan -W-W, Liu R, Watt C-L, Chan W-M, Lai K-Y, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis [Internet]. 2011;52:447–56. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/21248066
- Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med [Internet] 2006;145:599–609. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/16940336
- Wu -X-X, Gao H-N, Wu H-B, Peng X-M, Ou H-L, Li L-J. Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma. Int J Infect Dis [Internet]. 2015;41:3–5. [accessed 2016 Aug 7] http://www.ncbi.nlm.nih.gov/pubmed/26482389
- Kong LK, Zhou BP. Successful treatment of avian influenza with convalescent plasma. Hong Kong Med J [Internet]. 2006;12:489. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/17148811.
- Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw F-M, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis [Internet]. 2015;211:80–90. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/25030060
- Hung IFN, To KKW, Lee C-K, Lee K-L, Yan -W-W, Chan K, Chan W-M, C-W N, Law K-I, Chow F-L, et al. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest [Internet]. 2013;144:464–73. [accessed 2020 May 2]. http://www.ncbi.nlm.nih.gov/pubmed/23450336
- Davey RT, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, et al. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Lancet Respir Med. 2019;7:951–63. doi:https://doi.org/10.1016/S2213-2600(19)30253-X.
- Beigel JH, Aga E, Elie-Turenne M-C, Cho J, Tebas P, Clark CL, Metcalf JP, Ozment C, Raviprakash K, Beeler J, et al. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. Lancet Respir Med [Internet]. 2019;7:941–50. [accessed 2020 May 6]. http://www.ncbi.nlm.nih.gov/pubmed/31582360
- Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc R pathway. J Virol. 2011;85:10582–97. doi:https://doi.org/10.1128/JVI.00671-11.
- Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4(4):e123158.
- Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)–possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis [Internet]. 2013;17:e792–8. http://www.ncbi.nlm.nih.gov/pubmed/23993766
- Cheng Y, Wong R, Soo YOY, Wong WS, Lee CK, Ng MHL, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. doi:https://doi.org/10.1007/s10096-004-1271-9.
- Soo YOY, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KKS, Ng MHL, Chan P, Cheng G, Sung JJY. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10:676–78. doi:https://doi.org/10.1111/j.1469-0691.2004.00956.x.
- Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus [Internet]. 2015;4:709. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/26618098
- Arabi YM, Hajeer AH, Luke T, Raviprakash K, Balkhy H, Johani S, Al-Dawood A, Al-Qahtani S, Al-Omari A, Al-Hameed F, et al. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg Infect Dis [Internet]. 201622:1554–61. [accessed 2016 Sep 21]. http://www.ncbi.nlm.nih.gov/pubmed/27532807
- Alshukairi AN, Khalid I, Ahmed WA, Dada AM, Bayumi DT, Malic LS, Althawadi S, Ignacio K, Alsalmi HS, Al-Abdely HM, et al. Antibody response and disease severity in healthcare worker MERS survivors. Emerg Infect Dis [Internet]. 2016;22. [accessed 2016 Aug 7]. http://www.ncbi.nlm.nih.gov/pubmed/27192543
- Drosten C, Meyer B, Müller MAMA, Corman VMVM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJBJ, Lattwein E, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med [Internet]. 2014; 371:828–35. http://www.ncbi.nlm.nih.gov/pubmed/25162889
- Alrashid M, Taleb A, Hajeer A, Arabi Y. Prevalence of antibodies against the middle east respiratory syndrome coronavirus, influenza A and B viruses among blood donors, Saudi Arabia. Ann Thorac Med. 2017;12:217–18. doi:https://doi.org/10.4103/atm.ATM_143_17.
- Corman VM, Albarrak AM, Omrani AS, Albarrak MM, Farah ME, Almasri M, Muth D, Sieberg A, Meyer B, Assiri AM, et al. Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection. Clin Infect Dis [Internet] 2015. http://www.ncbi.nlm.nih.gov/pubmed/26565003.
- Park WB, Perera RAPM, Choe PG, Lau EHY, Choi SJ, Chun JY, Oh HS, Song KH, Bang JH, Kim ES, et al. Kinetics of serologic responses to mers coronavirus infection in humans, South Korea. Emerg Infect Dis. 2015;21:2186–89. doi:https://doi.org/10.3201/eid2112.151421.
- Tanne JH. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients. BMJ. 2020;368:m1256. doi:https://doi.org/10.1136/bmj.m1256.
- Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, et al. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Chest [Internet]. [accessed 2020 Apr 7]. https://www.sciencedirect.com/science/article/pii/S0012369220305717?dgcid=rss_sd_all&utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound
- Wong HK, Lee CK. Pivotal role of convalescent plasma in managing emerging infectious diseases. Vox Sang. 2020. doi:https://doi.org/10.1111/vox.12927.
- Tiberghien P, de Lambalerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how. Vox Sang. 2020. doi:https://doi.org/10.1111/vox.12926.
- Zhang L, Pang R, Xue X, Bao J, Ye S, Dai Y, Zheng Y, Fu Q, Hu Z, Yi Y. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19. Aging (Albany NY). 2020 Apr 22;12(8):6536–6542.
- Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, et al. Treatment with convalescent plasma for critically Ill Patients with SARS-CoV-2 infection. Chest. 2020. doi:https://doi.org/10.1016/j.chest.2020.03.039.
- Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom JS, et al. Use of convalescent plasma therapy in two covid-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020 Apr 13;35(14):e149.
- Çınar OE, Sayınalp B, Aladağ Karakulak E, Avşar Karataş A, Velet M, AÇ İ, Ersoy Ortaç NE, Öcal S, Aksu S, Haznedaroğlu İC, et al. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis. Transfus Apher Sci. 2020. doi:https://doi.org/10.1016/j.transci.2020.102821.
- Kong Y, Cai C, Ling L, Zeng L, Wu M, Wu Y, Zhang W, Liu Z. Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma. Transfus Apher Sci [Internet]. 2020:102820. [accessed 2020 Jun 5]. https://linkinghub.elsevier.com/retrieve/pii/S1473050220301154
- Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, Xia X, Lv T. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol. 2020. doi:https://doi.org/10.1002/jmv.25882.
- Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank T, Bernard DW, Eagar TN, Long SW, et al. Treatment of COVID-19 patients with convalescent plasma. Am J Pathol [Internet]. 2020 [accessed 2020 Jun 5]. https://linkinghub.elsevier.com/retrieve/pii/S0002944020302571
- Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial. JAMA [Internet]. 2020. [accessed 2020 Jun 5]. http://www.ncbi.nlm.nih.gov/pubmed/32492084
- Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JRA, et al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. J Clin Invest [Internet]. 2020. [accessed 2020 Jun 12]. http://www.jci.org/articles/view/140200
- Knudson CM, Jackson JB. COVID‐19 convalescent plasma: phase 2. Transfusion [Internet]. 2020. [accessed 2020 May 15]. https://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15842.
- Barone P, DeSimone RA. Convalescent plasma to treat coronavirus disease 2019 (COVID‐19): considerations for clinical trial design. Transfusion [Internet]. 2020. [accessed 2020 May 15]. https://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15843.